VISTA on macrophages is likely to be a promising target for immune checkpoint inhibition, because it is expressed most often in human PDAC (48) and reversing the M2 phenotype to an M1-like profile through VISTA ICI will result in an inflammatory anti-tumor reaction. This evidence concerns the gene VSIR and neoplasm.